UNSPSC 41131717: Electrophoretic hemoglobin analysis system

In this classification an electrophoretic hemoglobin analysis system is a device that electrophoretically separates and identifies normal and abnormal hemoglobin types as an aid in the diagnosis of anemia or erythrocytosis (increased total red cell mass) due to a hemoglobin abnormality US FDA regulates Electrophoretic hemoglobin analysis system under 21 CFR 864.7440 and under FDA product code OOX.

UNSPSC 41131717 Electrophoretic hemoglobin analysis system is a Commodity code that in practice covers drug testing supplies, laboratory consumables, and reagents for forensic and clinical drug screening rather than hemoglobin analysis equipment. State and local governments procure drug testing kits, panel-screening supplies, confirmatory reagents, collection materials, and calibration standards for use in community corrections programs, county health services, forensic laboratories, and occupational health screening. The issuing-body mix spans county criminal-justice and community-corrections departments (Collin County, Texas), county health agencies (Collin County Health Care Services), city municipal procurement (Charlotte, North Carolina), state forensic and public-safety laboratories (Texas Department of Public Safety, Texas Department of Parks and Wildlife, Oregon Health Authority), county sheriffs and forensic units (Pinellas County, Florida), and regional treatment courts (Benton County, Oregon). A few jurisdictions appear more than once—Collin County in particular has recently posted separate solicitations for offender specimen collection and drug testing services and for general laboratory services—signaling sustained demand for drug screening and lab capacity.

Geographic activity concentrates in Texas (Collin County, Texas Comptroller of Public Accounts), Florida (Seminole County, Pinellas County), and Oregon (State of Oregon, Benton County), with additional recent solicitations from Georgia (Gwinnett County) and North Carolina (City of Charlotte). Representative recent opportunities include Collin County's RFP 2026-327 for offender specimen collection and drug testing services (due July 23, 2026, estimated value $600,000, two-year initial term with three optional one-year renewals) covering immunoassay screening with LC/MS/MS or GC/MS confirmation for approximately 25,031 tests annually; the Texas Comptroller's IFB 304T-27-175A1.1 for proprietary chemical laboratory equipment and supplies (due October 20, 2026) sourcing DNA analyzers, sequencing kits, and Direct ELISA kits for detecting opiates, cocaine, amphetamines, benzodiazepines, and cannabinoids for statewide delivery; and Benton County's RFP SC0200300017 for urinalysis testing services (due July 7, 2026) requiring twice-weekly panel testing with confirmatory analysis and secure web-based result reporting for a family treatment court program.